Physician Payment Data is Where the Action Is
Look beyond the EHR incentive program. A national effort to turn CMS's recent release of Medicare physician payment data into useful, actionable data visualizations is the hottest HIT challenge right now.
The Changing World of Oncology Reimbursement – Are You Ready?
The expenses associated with cancer care in the United States are staggering and only expected to climb.
Chronic Prostate Inflammation May Increase Prostate Cancer Risk
Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer, according to researchers.
Bavituximab and Ipilimumab Combination Trial to be Initiated in Patients With Advanced Melanoma
Randomized trial to evaluate immune activation following treatment with immunotherapy combination. The open label design will allow for ongoing evaluation of clinical results from study.
Liquid Biopsy to Identify CTCs and Guide Treatment Decisions in Bladder Cancer
A blood test performed before radical cystectomy in patients with urothelial cancer of the bladder could identify the presence of circulating tumor cells (CTCs), which are predictive of outcome, according to a new study.
Fauci, Leading AIDS Researchers Discuss Vaccine Prospects in AJMC’s Latest “Evidence-Based” Title
Evidence-Based Immunology and Infectious Disease, the fourth title in the news series from The American Journal of Managed Care, launches with an issue that features interviews with leading AIDS researchers, a discussion of the challenges of paying for breakthrough therapies for hepatitis C, and new information on causes and treatments for rheumatoid arthritis.
ER Visits For Routine Dental Care Driving Up Hospital Costs
People who go to Michigan hospitals seeking treatment for dental conditions that could have been prevented through regular dental care increase health care costs by millions of dollars in the state.
CMS to Private Insurers: Adopt Payment Reforms More Quickly
Leaders from the Centers for Medicare & Medicaid Services think private insurers have been too slow to adopt payment reforms, but they would be best served by adopting value-based payment systems in tandem with CMS today.
FDA Advisory Committee Votes Against Moxduo Approval
- QRxPharma (ASX: QRX and OTCQX: QRXPY) announced today that the United States Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee has voted to recommend against approval of Moxduo, an immediate release Dual Opioid® for the treatment of moderate to severe acute pain. The Advisory Committee found the Company did not provide sufficient evidence to warrant approval of Moxduo at this time.
Medicare Chief Jonathan Blum Leaving Obama Administration
The Obama administration's top Medicare official is stepping down from his post. CMS Principal Deputy Administrator Jonathan Blum has been with the agency for more than five years.
Waiting For Medicaid To Kick In
Nearly 2 million Californians have gained coverage with the expansion of the Medi-Cal program for poor and disabled people, including those who transitioned from temporary programs like Healthy Way LA. But roughly 800,000 more applications are pending from people presumed to be eligible for the program.
Looking at Costs and Risks, Many Skip Health Insurance
A poll of uninsured people in December found that of those who did not plan to get coverage, half said that cost was the main reason. Nearly 3 in 10 said they objected to the government’s requiring it, while about one in 10 said they felt they did not need it.
MiR-21 as a Prognostic Factor for NSCLC
MicroRNA (miR)-21 has been revealed as an oncogene in cancer development, and is one of the miRNAs closely connected to angiogenesis. The authors aimed to explore the impact of miR-21 expression in both tumor and stromal compartments of non-small cell lung cancer (NSCLC), and correlations between miR-21 and angiogenic protein markers.
Eli Lilly's Cyramza Approved for Stomach Cancer
The U.S. Food and Drug Administration today approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach.
Gentic Variant for Difficult-to-Treat Invasive Lobular Carcinoma Identified
The discovery of the genetic variant, in conjunction with other markers, could help in the development of future genetic screening tools to assess women's risk of developing invasive lobular cancer, and also gives researchers important new clues about the genetic causes of the disease and a related precursor to cancer called lobular carcinoma in situ.
HIX Enrollment Closed, Risk Assignment Challenges Start
The Obama administration is boasting that 8 million Americans, including a good number of young people, have enrolled in public exchange plans. The big question now is how will new members fit into the risk adjustment puzzle?
Deal Volume Dips While Value Soars in First Quarter
Across the country, a historically fragmented hospital market is organizing around a select group of for-profit and not-for-profit systems. And that means competition has increased for fewer acquisition targets that still remain on the market.
Give ACOs a break, AHA tells CMS Innovation Center
The American Hospital Association is lobbying the CMS Innovation Center to make it easier for accountable care organizations to earn Medicare bonuses and delay potential penalties as the agency looks to expand the initiative.
Consumption of Processed Meat May Increase the Risk of Colorectal Cancer in Some
Dietary factors, including meat, fruits, vegetables and fiber, are associated with colorectal cancer; however, there is limited information as to whether these dietary factors interact with genetic variants to modify risk of colorectal cancer. In this study, the authors conducted genome-wide association studies between genetic variants, diet, and the susceptibility to colorectal cancer.
AJMC Studies: Barriers to Newer Antipsychotic Drugs Can Drive Up Other Medical Costs, Reduce Adherence
Two new studies in The American Journal of Managed Care find that state Medicaid restrictions on access to newer antipsychotic drugs save little in the short run, and may cost more later when patients fail to stay on their medication, end up in the hospital, or both.
AstraZeneca and Pfizer Collaborate on a New Oncology Trial Design
Drug giants AstraZeneca and Pfizer are working on a new clinical trial design, to be launched in Britain in July or August of this year, to include multiple drugs for evaluation in a single trial. This is expected to be both time and cost saving and could significantly hasten drug development.
VA, California Panels Urge Costly Hepatitis C Drugs For Sickest Patients
Doctors should consider expensive new hepatitis C drugs for patients with advanced liver disease, including those awaiting transplants, but ask most others to wait for drugs in development, the Department of Veterans Affairs said Wednesday.
Health Insurance Gains Since Last Fall Hit 12 Million, Survey Shows
President Obama’s health law has led to an even greater increase in health coverage than previously estimated, according to new Gallup survey data, which suggest that about 12 million previously uninsured Americans have gained coverage since last fall.